Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: South Korea Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20141
20152
20161
20174
20194
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center3
ASLAN Pharmaceuticals1
Basilea Pharmaceutica1
Changhoon Yoo1
EMD Serono Research & Development Institute, Inc.1
Elevation Oncology1
Fore Biotherapeutics1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma19
Biliary Tract Neoplasms8
Esophageal Neoplasms5
Gallbladder Neoplasms5
Carcinoma, Hepatocellular4
Ovarian Neoplasms4
Bile Duct Neoplasms3
Breast Neoplasms3
Colorectal Neoplasms3
Pancreatic Neoplasms3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.